What’s Next in Biotech: The Future of Licensing and New-Company Creation
Join us for the next episode of What’s Next in Biotech, for a conversation between Gunderson Dettmer Life Sciences partner and host Tim Ehrlich and Senior Vice President of Research Innovation Irene Abrams of Boston Children’s Hospital.
They’ll discuss how research institutions approach licensing and new-company creation, what’s changing, and what founders and executives should know when partnering with an institution.
Featured Insights
Featured Insights
Client News
Client News

